Australia: Shares end flat as miners offset gains in tech, health stocks
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] Australian shares were little changed on Wednesday (Dec 22) with gains in technology and healthcare segments countered by a slump in mining stocks, as worries over the economic fallout from the Omicron coronavirus variant kept investors on the edge.
The S&P/ASX 200 index closed 0.1 per cent higher at 7,364.8 points. The benchmark had gained 0.9 per cent on Tuesday (Dec 21).
Australia conducted an emergency national cabinet meeting on Wednesday where more vaccination funding was announced, as the country reported more than 5,000 daily Covid-19 infections for the first time during the pandemic.
A jump in coronavirus cases globally, just days before Christmas, has led to social mobility restrictions in some countries, threatening economic activity.
Miners were among top losers in Australia, reversing course to drop 0.4 per cent as iron ore futures declined on possible Covid-19 curbs in China.
Global miner BHP Group slid 0.8 per cent, while rival Rio Tinto fell 2 per cent.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
There's some weakness in steel manufacturing and property prices in China again and markets are waking up to the fact that iron ore's recent rally was going to be unsustainable, said Mathan Somasundaram, chief executive of Deep Data Analytics.
Gold stocks eased 1 per cent, led by a 3.7 per cent fall in Regis Resources.
Gold miner Falcon Metals, not part of the sub-index, sank 37 per cent in its market debut and was the top laggard on the main index.
Technology stocks closed higher for a third day, with share registry firm Link Administration Holdings leading gains on the sub-index and on the benchmark, surging 15 per cent on accepting a C$3.2 billion (S$3.4 billion) buyout offer from a Canadian company.
Health sector rose 0.8 per cent, led by Polynovo and Pro Medicus gaining 4.8 per cent and 2.2 per cent, respectively.
New Zealand's benchmark S&P/NZX 50 index firmed 0.07 per cent to 12,865.2 points, with pharmaceutical company EBOS Group leading the gains.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant